Vera Therapeutics (VERA) Notes Payables (2021 - 2026)
Vera Therapeutics posted quarterly Notes Payables of $75.0 million for Q1 2026, up 50.0% year-on-year from $50.0 million in Q1 2025, and little changed on a QoQ basis from $75.0 million in Q4 2025.
Vera Therapeutics (VERA) has 6 years of Notes Payables data on file, last reported at $75.0 million in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables rose 50.0% year-over-year to $75.0 million; the trailing twelve-month figure through Mar 2026 stood at $75.0 million (up 50.0% YoY), and the FY2025 full-year result was $75.0 million, up 50.0% from the prior year.
- Notes Payables for Q1 2026 stood at $75.0 million, roughly flat from $75.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $75.0 million in Q2 2025 and bottomed at $25.0 million in Q4 2022.
- The 5-year median for Notes Payables is $50.0 million (2023), against an average of $50.0 million.
- The widest annual swing landed in 2022, when Notes Payables soared 400.0%; it then changed 0.0% in 2024.
- A 5-year view of Notes Payables shows it stood at $25.0 million in 2022, then soared by 100.0% to $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then surged by 50.0% to $75.0 million in 2025, then changed by 0.0% to $75.0 million in 2026.
- The last three Notes Payables figures came in at $75.0 million (Q1 2026), $75.0 million (Q4 2025), and $75.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 75.00 Mn |
| Jun 30, 2025 | 75.00 Mn |
| Mar 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | 50.00 Mn |
| Dec 31, 2023 | 50.00 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 25.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Dec 31, 2021 | 5.00 Mn |